Kailera Therapeutics
About Kailera Therapeutics
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: IPO T: - FT: IPO |
A: 718800000 MR: - FA: $718.8 million FAN: 718800000 |
D: 2026-04-20 FD: 2026-04-20 |
6 investors |
| 2 |
RT: IPO T: - FT: IPO |
A: 625000000 MR: - FA: $625.0 million FAN: 625000000 |
D: 2026-04-16 FD: 2026-04-16 |
6 investors |
| 3 |
RT: Series B T: - FT: Series B |
A: 600000000 MR: - FA: $600 million FAN: 600000000 |
D: 2025-10-14 FD: 2025-10-14 |
15 investors |
| 4 |
RT: Series A T: - FT: Series A |
A: 400000000 MR: - FA: $400 million FAN: 400000000 |
D: 2024-10-01 FD: 2024-10-01 |
4 investors |
Growth Metrics
Team & Leadership
Ron Renaud
President & Chief Executive Officer
Ron Renaud
President & Chief Executive Officer
Scott Akamine
Chief Legal Officer
Paul Burgess
Chief Operating Officer & Chief Business Officer
Paula Cloghessy
Chief People Officer
Jamie Coleman
Chief Commercial Officer
Recent News
Kailera Therapeutics Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- kailera.com
- Industries
- Biopharmaceuticals
- Company Size
- ~120 employees (est.)
- Locations
- Waltham, MA and San Diego, CA
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro